Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ADRIAMYCIN CARDIOTOXICITY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 98 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Verrill, M
      Anthracyclines in breast cancer: therapy and issues of toxicity

      BREAST
    2. Dazzi, H; Kaufmann, K; Follath, F
      Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia- Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity inpatients treated for acute leukaemia at theUniversity Hospital of Zurich, Switzerland, between 1990 and 1996

      ANNALS OF ONCOLOGY
    3. Batist, G; Ramakrishnan, G; Rao, CS; Chandrasekharan, A; Gutheil, J; Guthrie, T; Shah, P; Khojasteh, A; Nair, MK; Hoelzer, K; Tkaczuk, K; Park, YC; Lee, LW
      Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    4. Kremer, LCM; van Dalen, EC; Offringa, M; Ottenkamp, J; Voute, PA
      Anthracycline-induced clinical heart failure in a cohort of 607 children: Long-term follow-up study

      JOURNAL OF CLINICAL ONCOLOGY
    5. Iarussi, D; Galderisi, M; Ratti, G; Tedesco, MA; Indolfi, P; Casale, F; Di Tullio, MT; de Divitiis, O; Iacono, A
      Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood

      CLINICAL CARDIOLOGY
    6. De Beer, EL; Bottone, AE; Voest, EE
      Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Zhou, SY; Starkov, A; Froberg, MK; Leino, RL; Wallace, KB
      Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin

      CANCER RESEARCH
    8. Horenstein, MS; Vander Heide, RS; L'Ecuyer, TJ
      Molecular basis of anthracycline-induced cardiotoxicity and its prevention

      MOLECULAR GENETICS AND METABOLISM
    9. Eidenschink, AB; Schroter, G; Muller-Weihrich, S; Stern, H
      Myocardial high-energy phosphate metabolism is altered after treatment with anthracycline in childhood

      CARDIOLOGY IN THE YOUNG
    10. Birtle, AJ
      Anthracyclines and cardiotoxicity

      CLINICAL ONCOLOGY
    11. Kishi, S; Yoshida, A; Yamauchi, T; Tsutani, H; Lee, JD; Nakamura, T; Naiki, H; Ueda, T
      Torsade de pointes associated with hypokalemia after anthracycline treatment in a patient with acute lymphocytic leukemia

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    12. Cardinale, D; Sandri, MT; Martinoni, A; Tricca, A; Civelli, M; Lamantia, G; Cinieri, S; Martinelli, G; Cipolla, CM; Fiorentini, C
      Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    13. Herman, EH; Zhang, J; Chadwick, DP; Ferrans, VJ
      Comparison of the protective effects of amifostine and dexrazoxane againstthe toxicity of doxorubicin in spontaneously hypertensive rats

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    14. Iarussi, D; Indolfi, P; Galderisi, M; Bossone, E
      Cardiac toxicity after anthracycline chemotherapy in childhood

      HERZ
    15. Conklin, KA
      Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects

      NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
    16. Cirillo, R; Sacco, G; Venturella, S; Brightwell, J; Giachetti, A; Manzini, S
      Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    17. Weinstein, DM; Mihm, MJ; Bauer, JA
      Cardiac peroxynitrite formation and left ventricular dysfunction followingdoxorubicin treatment in mice

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    18. Fredericks, S; Collinson, PO; Holt, DW
      Response to "Increased creatine kinase MB and cardiac troponin T with normal cardiac troponin I in metastatic alveolar rhabdomyosarcoma"

      CLINICAL CHEMISTRY
    19. Pritsos, CA; Ma, J
      Basal and drug-induced antioxidant enzyme activities correlate with age-dependent doxorubicin oxidative toxicity

      CHEMICO-BIOLOGICAL INTERACTIONS
    20. Forrest, GL; Gonzalez, B; Tseng, W; Li, XL; Mann, J
      Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice

      CANCER RESEARCH
    21. Kawabata, H; Ryomoto, T; Ishikawa, K
      Effect of beta-blocker on metabolism and contraction of doxorubicin-induced cardiotoxicity in the isolated perfused rabbit heart

      ANGIOLOGY
    22. Nousiainen, T; Vanninen, E; Rantala, A; Jantunen, E; Hartikainen, J
      QT dispersion and late potentials during doxorubicin therapy for non-Hodgkin's lymphoma - Introduction

      JOURNAL OF INTERNAL MEDICINE
    23. Chan, S; Friedrichs, K; Noel, D; Pinter, T; Van Belle, S; Vorobiof, D; Duarte, R; Gil, MG; Bodrogi, I; Murray, E; Yelle, L; von Minckwitz, G; Korec, S; Simmonds, P; Buzzi, F; Mancha, RG; Richardson, G; Walpole, E; Ronzoni, M; Murawsky, M; Alakl, M; Riva, A; Crown, J
      Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    24. Herman, EH; Zhang, J; Lipshultz, SE; Rifai, N; Chadwick, D; Takeda, K; Yu, ZX; Ferrans, VJ
      Correlation between serum levels of cardiac troponin-T and the severity ofthe chronic cardiomyopathy induced by doxorubicin

      JOURNAL OF CLINICAL ONCOLOGY
    25. Gennari, A; Salvadori, B; Donati, S; Bengala, C; Orlandini, C; Danesi, R; Del Tacca, M; Bruzzi, P; Conte, PF
      Cardiotoxicity of epirubicin/paclitaxel-containing regimens: Role of cardiac risk factors

      JOURNAL OF CLINICAL ONCOLOGY
    26. Crown, J
      Phase III randomized trials of docetaxel in patients with metastatic breast cancer

      SEMINARS IN ONCOLOGY
    27. Levitt, G
      Cardioprotection

      BRITISH JOURNAL OF HAEMATOLOGY
    28. Suzuki, J; Yanagisawa, A; Shigeyama, T; Tsubota, J; Yasumura, T; Shimoyama, K; Ishikawa, K
      Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography

      ANGIOLOGY
    29. BOTTONE AE; VOEST EE; DEBEER EL
      IMPAIRMENT OF THE ACTIN-MYOSIN INTERACTION IN PERMEABILIZED CARDIAC TRABECULAE AFTER CHRONIC DOXORUBICIN TREATMENT

      Clinical cancer research
    30. BOTTONE AE; VOEST EE; DEBEER EL
      IMPAIRMENT OF THE ACTIN-MYOSIN INTERACTION IN PERMEABILIZED CARDIAC TRABECULAE AFTER CHRONIC DOXORUBICIN TREATMENT

      Clinical cancer research
    31. NOHL H; GILLE L; STANIEK K
      THE EXOGENOUS NADH DEHYDROGENASE OF HEART-MITOCHONDRIA IS THE KEY ENZYME RESPONSIBLE FOR SELECTIVE CARDIOTOXICITY OF ANTHRACYCLINES

      Zeitschrift fur Naturforschung. C, A journal of biosciences
    32. ALSHABANAH OA; BADARY OA; NAGI MN; ALGHARABLY NM; ALRIKABI AC; ALBEKAIRI AM
      THYMOQUINONE PROTECTS AGAINST DOXORUBICIN-INDUCED CARDIOTOXICITY WITHOUT COMPROMISING ITS ANTITUMOR-ACTIVITY

      Journal of experimental & clinical cancer research
    33. COTTIN Y; TOUZERY C; DALLOZ F; COUDERT B; TOUBEAU M; RIEDINGER A; LOUIS P; WOLF JE; BRUNOTTE F
      COMPARISON OF EPIRUBICIN AND DOXORUBICIN CARDIOTOXICITY INDUCED BY LOW-DOSES - EVOLUTION OF THE DIASTOLIC AND SYSTOLIC PARAMETERS STUDIED BY RADIONUCLIDE ANGIOGRAPHY

      Clinical cardiology
    34. MYERS C
      THE ROLE OF IRON IN DOXORUBICIN-INDUCED CARDIOMYOPATHY

      Seminars in oncology
    35. HERMAN EH; FERRANS V
      PRECLINICAL ANIMAL-MODELS OF CARDIAC PROTECTION FROM ANTHRACYCLINE-INDUCED CARDIOTOXICITY

      Seminars in oncology
    36. IMONDI AR
      PRECLINICAL MODELS OF CARDIAC PROTECTION AND TESTING FOR EFFECTS OF DEXRAZOXANE ON DOXORUBICIN ANTITUMOR EFFECTS

      Seminars in oncology
    37. SINGAL PK; ILISKOVIC N
      DOXORUBICIN-INDUCED CARDIOMYOPATHY

      The New England journal of medicine
    38. WISEMAN LR; SPENCER CM
      DEXRAZOXANE - A REVIEW OF ITS USE AS A CARDIOPROTECTIVE AGENT IN PATIENTS RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY

      Drugs
    39. SCHWARZ ER; POLLICK C; DOW J; PATTERSON M; BIRNBAUM Y; KLONER RA
      A SMALL ANIMAL-MODEL OF NONISCHEMIC CARDIOMYOPATHY AND ITS EVALUATIONBY TRANSTHORACIC ECHOCARDIOGRAPHY

      Cardiovascular Research
    40. VENDITTI P; BALESTRIERI M; DELEO T; DIMEO S
      FREE-RADICAL INVOLVEMENT IN DOXORUBICIN-INDUCED ELECTROPHYSIOLOGICAL ALTERATIONS IN RAT PAPILLARY-MUSCLE FIBERS

      Cardiovascular Research
    41. SCHAADT B; KELBAEK H
      AGE AND LEFT-VENTRICULAR EJECTION FRACTION IDENTIFY PATIENTS WITH ADVANCED BREAST-CANCER AT HIGH-RISK FOR DEVELOPMENT OF EPIRUBICIN-INDUCEDHEART-FAILURE

      Journal of nuclear cardiology
    42. HERMAN EH; FERRANS VJ
      ANIMAL-MODELS OF ANTHRACYCLINE CARDIOTOXICITY - BASIC MECHANISMS AND CARDIOPROTECTIVE ACTIVITY

      Progress in pediatric cardiology
    43. BOUCEK RJ
      MECHANISMS FOR ANTHRACYCLINE-INDUCED CARDIOMYOPATHY - CLINICAL AND LABORATORY CORRELATIONS

      Progress in pediatric cardiology
    44. PROPPER D; MASER E
      CARBONYL REDUCTION OF DAUNORUBICIN IN RABBIT LIVER AND HEART

      Pharmacology & toxicology
    45. WEIJL NI; CLETON FJ; OSANTO S
      FREE-RADICALS AND ANTIOXIDANTS IN CHEMOTHERAPY-INDUCED TOXICITY

      Cancer treatment reviews
    46. MAEDA A; HONDA M; KURAMOCHI T; TANAKA K; TAKABATAKE T
      AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR PROTECTS AGAINST DOXORUBICIN-INDUCED IMPAIRMENT OF CALCIUM HANDLING IN NEONATAL RAT CARDIAC MYOCYTES

      Clinical and experimental pharmacology and physiology
    47. DREICER R; KARWAL MW; MIDENCE G; DAVIS CS; NETTLEMAN M
      THE ROLE OF RADIONUCLIDE ANGIOCARDIOGRAPHY IN THE TREATMENT OF PATIENTS RECEIVING DOXORUBICIN-BASED CHEMOTHERAPY - A REASSESSMENT

      American journal of clinical oncology
    48. KAKADEKAR AP; SANDOR GGS; FRYER C; CHAN KW; ROGERS PC; PRITCHARD S; POPOV R
      DIFFERENCES IN DOSE SCHEDULING AS A FACTOR IN THE ETIOLOGY OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN EWING SARCOMA PATIENTS

      Medical and pediatric oncology
    49. PALMEIRA CM; SERRANO J; KUEHL DW; WALLACE KB
      PREFERENTIAL OXIDATION OF CARDIAC MITOCHONDRIAL-DNA FOLLOWING ACUTE INTOXICATION WITH DOXORUBICIN

      Biochimica et biophysica acta. Bioenergetics
    50. LEISCHIK R; EISING EG; KATZ M; GLATTKI G; BRUCH C; SEEBER S; BOCKISCH A; ERBEL R
      STRESS ECHOCARDIOGRAPHY COMPARED WITH RAD IONUCLIDE VENTRICULOGRAPHY IN THE DIAGNOSIS OF CARDIOMYOPATHY IN PATIENTS RECEIVING CHEMOTHERAPY FOR MALIGNANT-TUMOR

      Deutsche Medizinische Wochenschrift
    51. FERRARI S; FIGUS E; CAGNANO R; IANTORNO D; BACCI G
      THE ROLE OF CORRECTED QT INTERVAL IN THE CARDIOLOGIC FOLLOW-UP OF YOUNG-PATIENTS TREATED WITH ADRIAMYCIN

      Journal of chemotherapy
    52. PIHKALA J
      ANTHRACYCLINE CARDIOMYOPATHY AND IMPAIRED MYOCARDIAL-FUNCTION IN CHILDREN - OUTCOME WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR AND DIGOXIN THERAPY

      International journal of pediatric hematology/oncology
    53. COTTIN Y; TOUZERY C; COUDERT B; RICHEBOURG S; COHEN M; TOUBEAU M; LOUIS P; WOLF JE; BRUNOTTE F
      DIASTOLIC OR SYSTOLIC LEFT AND RIGHT-VENTRICULAR IMPAIRMENT AT MODERATE DOSES OF ANTHRACYCLINE - A 1-YEAR FOLLOW-UP-STUDY OF WOMEN

      European journal of nuclear medicine
    54. ROMEROALVIRA D; ROCHE E; PLACER L
      CARDIOMYOPATHIES AND OXIDATIVE STRESS

      Medical hypotheses
    55. HOYANO Y; FURUKAWA Y; OGUCHI T; KASAMA M; IMAMURA H; CHIBA S
      ACUTE PRESYNAPTIC INHIBITION BY DOXORUBICIN OF NEGATIVE CHRONOTROPIC AND INOTROPIC RESPONSES TO PARASYMPATHETIC NERVE-STIMULATION IN ISOLATED, BLOOD-PERFUSED DOG ATRIUM

      Journal of cardiovascular pharmacology
    56. DORR RT
      CYTOPROTECTIVE AGENTS FOR ANTHRACYCLINES

      Seminars in oncology
    57. DEWOLF D; SUYS B; MAURUS R; BENOIT Y; VERHAAREN H; MATTHIJS D; OTTEN J
      DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN THE EVALUATION OF LATE ANTHRACYCLINE CARDIOTOXICITY IN CHILDHOOD-CANCER SURVIVORS

      Pediatric research
    58. GANZ WI; SRIDHAR KS; GANZ SS; GONZALEZ R; CHAKKO S; SERAFINI A
      REVIEW OF TESTS FOR MONITORING DOXORUBICIN-INDUCED CARDIOMYOPATHY

      Oncology
    59. SOLEM LE; HELLER LJ; WALLACE KB
      DOSE-DEPENDENT INCREASE IN SENSITIVITY TO CALCIUM-INDUCED MITOCHONDRIAL DYSFUNCTION AND CARDIOMYOCYTE CELL INJURY BY DOXORUBICIN

      Journal of Molecular and Cellular Cardiology
    60. ANDREANI A; RAMBALDI M; LEONI A; LOCATELLI A; BOSSA R; FRACCARI A; GALATULAS I; SALVATORE G
      POTENTIAL ANTITUMOR AGENTS .24. SYNTHESIS AND PHARMACOLOGICAL BEHAVIOR OF IMIDAZO[2,1-B]THIAZOLE GUANYLHYDRAZONES BEARING AT LEAST ONE CHLORINE

      Journal of medicinal chemistry
    61. KOJIMA S
      NEOPTERIN AS AN ENDOGENOUS ANTIOXIDANT

      Eisei Kagaku
    62. CHAN EM; THOMAS MJ; BANDY B; TIBBITS GF
      EFFECTS OF DOXORUBICIN, 4'-EPIRUBICIN, AND ANTIOXIDANT ENZYMES ON THECONTRACTILITY OF ISOLATED CARDIOMYOCYTES

      Canadian journal of physiology and pharmacology
    63. BULOCK FA; MOTT MG; OAKHILL A; MARTIN RP
      EARLY IDENTIFICATION OF ANTHRACYCLINE CARDIOMYOPATHY - POSSIBILITIES AND IMPLICATIONS

      Archives of Disease in Childhood
    64. SHAN K; LINCOFF AM; YOUNG JB
      ANTHRACYCLINE-INDUCED CARDIOTOXICITY

      Annals of internal medicine
    65. PIERGIES AA; BENSON AB
      PHARMACOKINETICS AND ACUTE CARDIOVASCULAR EFFECTS OF MENOGARIL IN PATIENTS WITH METASTATIC TUMORS

      International journal of clinical pharmacology and therapeutics
    66. LLESUY S; MILEI J; PICONE V; FLECHA BG; BEIGELMAN R; BOVERIS A
      EFFECT OF VITAMIN-A AND VITAMIN-E ON ISCHEMIA-REPERFUSION DAMAGE IN RABBIT HEART

      Molecular and cellular biochemistry
    67. FINK FM; GENSER N; FINK C; FALK M; MAIR J; MAURERDENGG K; HAMMERER I; PUSCHENDORF B
      CARDIAC TROPONIN-T AND CREATINE-KINASE MB MASS CONCENTRATIONS IN CHILDREN RECEIVING ANTHRACYCLINE CHEMOTHERAPY

      Medical and pediatric oncology
    68. STEINHERZ LJ; STEINHERZ PG; TAN C
      CARDIAC-FAILURE AND DYSRHYTHMIAS 6-19 YEARS AFTER ANTHRACYCLINE THERAPY - A SERIES OF 15 PATIENTS

      Medical and pediatric oncology
    69. YAMASHITA J; OGAWA M; SHIRAKUSA T
      PLASMA ENDOTHELIN-1 AS A MARKER FOR DOXORUBICIN CARDIOTOXICITY

      International journal of cancer
    70. COTTIN Y; TOUZERY C; COUDERT B; GILLES A; WALKER P; MASSING JL; TOUBEAU M; RIEDINGERBERRIOLO A; CAILLOT D; LOUIS P; WOLF JE; BRUNOTTE F
      IMPAIRMENT OF DIASTOLIC FUNCTION DURING SHORT-TERM ANTHRACYCLINE CHEMOTHERAPY

      British Heart Journal
    71. SEIFERT CF; NESSER ME; THOMPSON DF
      DEXRAZOXANE IN THE PREVENTION OF DOXORUBICIN-INDUCED CARDIOTOXICITY

      The Annals of pharmacotherapy
    72. VALAGUSSA P; ZAMBETTI M; BIASI S; MOLITERNI A; ZUCALI R; BONADONNA G
      CARDIAC EFFECTS FOLLOWING ADJUVANT CHEMOTHERAPY AND BREAST IRRADIATION IN OPERABLE BREAST-CANCER

      Annals of oncology
    73. ROSSI F; FILIPPELLI W; RUSSO S; FILIPPELLI A; BERRINO L
      CARDIOTOXICITY OF DOXORUBICIN - EFFECTS OF DRUGS INHIBITING THE RELEASE OF VASOACTIVE SUBSTANCES

      Pharmacology & toxicology
    74. HIRANO S; WAKAZONO K; AGATA N; IGUCHI H; TONE H
      COMPARISON OF CARDIOTOXICITY OF PIRARUBICIN, EPIRUBICIN AND DOXORUBICIN IN THE RAT

      Drugs under experimental and clinical research
    75. HERMAN EH; ZHANG J; FERRANS VJ
      COMPARISON OF THE PROTECTIVE EFFECTS OF DESFERRIOXAMINE AND ICRF-187 AGAINST DOXORUBICIN-INDUCED TOXICITY IN SPONTANEOUSLY HYPERTENSIVE RATS

      Cancer chemotherapy and pharmacology
    76. ADAM Z; ELBL L; VORLICEK J; HAJEK R; HAJEK D; HEJLOVA N; KRALOVA E; NOVOTNA H
      TREATMENT OF REFRACTORY MULTIPLE-MYELOMA WITH VINCRISTINE, ADRIAMYCIN, DEXAMETHASONE, AND WITH REPEATED APPLICATION OF CYCLOPHOSPHAMIDE (C-VAD)

      Acta medica austriaca
    77. KOJIMA S; IIZUKA H; YAMAGUCHI H; TANUMA S; KOCHI M; UENO Y
      ANTIOXIDATIVE ACTIVITY OF BENZYLIDENEASCORBATE AND ITS EFFECT ON ADRIAMYCIN-INDUCED CARDIOTOXICITY

      Anticancer research
    78. OYAMADA H; YAMADA Y; NOMURA E; NAKANISHI Y; ABE S; HORIKOSHI N; OGIHARA A; AIBA K; INAMOTO Y
      RELIABILITY OF DATA OBTAINED BY RADIONUCLIDE ANGIOCARDIOGRAPHY IN FOLLOW-UP-STUDIES WITH SPECIAL REFERENCE TO INTRAOBSERVER AND INTEROBSERVER VARIATIONS

      Nuclear medicine communications
    79. SOLEM LE; HENRY TR; WALLACE KB
      DISRUPTION OF MITOCHONDRIAL CALCIUM HOMEOSTASIS FOLLOWING CHRONIC DOXORUBICIN ADMINISTRATION

      Toxicology and applied pharmacology
    80. ALI MK; EWER MS; GIBBS HR; SWAFFORD J; GRAFF KL
      LATE DOXORUBICIN-ASSOCIATED CARDIOTOXICITY IN CHILDREN - THE POSSIBLEROLE OF INTERCURRENT VIRAL-INFECTION

      Cancer
    81. JIANG JH; TEMMA K; AKERA T
      DOXORUBICIN-INDUCED CHANGES IN INTRACELLULAR CA2-PIG HEART( TRANSIENTS OBSERVED IN CARDIAC MYOCYTES ISOLATED FROM GUINEA)

      Canadian journal of physiology and pharmacology
    82. COTTIN Y; RIBUOT C; MAUPOIL V; GODIN D; ARNOULD L; BRUNOTTE F; ROCHETTE L
      EARLY INCIDENCE OF ADRIAMYCIN TREATMENT ON CARDIAC PARAMETERS IN THE RAT

      Canadian journal of physiology and pharmacology
    83. BAUER G; OCONNELL S; DEVEREUX D; MARTIN A
      REVERSAL OF DOXORUBICIN-IMPAIRED WOUND-HEALING USING TRIAD COMPOUND

      The American surgeon
    84. BAUER G; OCONNELL S; DEVEREUX D
      REVERSAL OF DOXORUBICIN-IMPAIRED WOUND-HEALING USING TRIAD COMPOUND

      The American surgeon
    85. GUSTAFSON DL; SWANSON JD; PRITSOS CA
      MODULATION OF GLUTATHIONE AND GLUTATHIONE-DEPENDENT ANTIOXIDANT ENZYMES IN MOUSE HEART FOLLOWING DOXORUBICIN THERAPY

      Free radical research communications
    86. FERRARI E; TAILLAN B; DUJARDIN P; MORAND P
      CARDIOTOXICITY OF ANTHRACYCLINES - CLINICAL-FEATURES, INCIDENCE, MONITORING

      La Presse medicale
    87. SCHWARTZ CL; HOBBIE WL; TRUESDELL S; CONSTINE LC; CLARK EB
      CORRECTED QT INTERVAL PROLONGATION IN ANTHRACYCLINE-TREATED SURVIVORSOF CHILDHOOD-CANCER

      Journal of clinical oncology
    88. HERMAN EH; FERRANS VJ
      TIMING OF TREATMENT WITH ICRF-187 AND ITS EFFECT ON CHRONIC DOXORUBICIN CARDIOTOXICITY

      Cancer chemotherapy and pharmacology
    89. LAUNCHBURY AP; HABBOUBI N
      EPIRUBICIN AND DOXORUBICIN - A COMPARISON OF THEIR CHARACTERISTICS, THERAPEUTIC ACTIVITY AND TOXICITY

      Cancer treatment reviews
    90. MCLOON LK; LUO XX; WIRTSCHAFTER J
      ACUTE MORPHOLOGIC CHANGES IN ORBICULARIS OCULI MUSCLE AFTER DOXORUBICIN INJECTION INTO THE EYELID

      Muscle & nerve
    91. EMBREE L; GELMON KA; LOHR A; MAYER LD; COLDMAN AJ; CULLIS PR; PALAITIS W; PILKIEWICZ F; HUDON NJ; HEGGIE JR; GOLDIE JH
      CHROMATOGRAPHIC ANALYSIS AND PHARMACOKINETICS OF LIPOSOME-ENCAPSULATED DOXORUBICIN IN NON-SMALL-CELL LUNG-CANCER PATIENTS

      Journal of pharmaceutical sciences
    92. DODD DA; ATKINSON JB; OLSON RD; BUCK S; CUSACK BJ; FLEISCHER S; BOUCEK RJ
      DOXORUBICIN CARDIOMYOPATHY IS ASSOCIATED WITH A DECREASE IN CALCIUM RELEASE CHANNEL OF THE SARCOPLASMIC-RETICULUM IN A CHRONIC RABBIT MODEL

      The Journal of clinical investigation
    93. COWENS JW; CREAVEN PJ; GRECO WR; BRENNER DE; TUNG Y; OSTRO M; PILKIEWICZ F; GINSBERG R; PETRELLI N
      INITIAL CLINICAL (PHASE-I) TRIAL OF TLC D-99 (DOXORUBICIN ENCAPSULATED IN LIPOSOMES)

      Cancer research
    94. JAKACKI RI; LARSEN RL; BARBER G; HEYMAN S; FRIDMAN M; SILBER JH
      COMPARISON OF CARDIAC-FUNCTION TESTS AFTER ANTHRACYCLINE THERAPY IN CHILDHOOD - IMPLICATIONS FOR SCREENING

      Cancer
    95. RHODEN W; HASLETON P; BROOKS N
      ANTHRACYCLINES AND THE HEART

      British Heart Journal
    96. ICHO T; KOJIMA S; SHINOHARA N; KAJIWARA Y; KITABATAKE K; KUBOTA K
      PROTECTIVE EFFECTS OF TETRAHYDRONEOPTERIN AGAINST FREE RADICAL-INDUCED INJURY

      Biochemical pharmacology
    97. GAUDIN PB; HRUBAN RH; BESCHORNER WE; KASPER EK; OLSON JL; BAUGHMAN KL; HUTCHINS GM
      MYOCARDITIS ASSOCIATED WITH DOXORUBICIN CARDIOTOXICITY

      American journal of clinical pathology
    98. SOBOL MM; AMIET RG; GREEN MD
      INVITRO EVIDENCE FOR DIRECT COMPLEXATION OF ADR-529 187[(+)-1,2-BIS-(3,5-DIOXO-PIPERAZIN-1-YL)PROPANE] ONTO AN EXISTING FERRIC-ANTHRACYCLINE COMPLEX/

      Molecular pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 02:13:04